Poulsen P L, Ebbehøj E, Hansen K W, Mogensen C E
Medical Department M (Diabetes & Endocrinology), Aarhus University Hospital, Denmark.
Am J Hypertens. 1998 Sep;11(9):1093-9. doi: 10.1016/s0895-7061(98)00115-0.
Smoking is an important risk factor for the development and progression of diabetic nephropathy. The mechanisms by which smoking increases albuminuria and promotes nephropathy are unknown. Considering the acute pressor effect of smoking and the close association between blood pressure elevation and development of diabetic nephropathy, blood pressure increase might be implicated in the association between smoking and diabetic nephropathy. However, among nondiabetics, smokers have repeatedly been found to have lower blood pressure than nonsmokers. This is possibly mediated by an autonomic adjustment to sustained sympathetic stimulation by nicotine. Impaired modulation of the sympathovagal activity has been described in diabetes. In diabetic patients, the effect of smoking on blood pressure and autonomic function remains unclarified. We examined 24-h ambulatory blood pressure (oscillometric technique) and autonomic function (short-term power spectral analysis as well as conventional tests) in 24 smokers and 24 nonsmokers matched for sex, age, and diabetes duration. All patients were normoalbuminuric insulin-dependent diabetes mellitus patients. Smoking status was assessed by questionnaire with confirmatory determinations of urinary cotinine. Diabetic smokers had significantly higher 24-h mean arterial blood pressure (94+/-6.7 mm Hg compared to diabetic nonsmokers 90+/-5.8 mm Hg, P = .04) including higher diastolic nighttime blood pressure (68+/-7.3 mm Hg v 64+/-5.2 mm Hg, P = .03). Smokers also had significantly higher 24-h heart rate (80+/-7.2 compared to 72+/-9.2 beats/min, P < .001). In addition, smoking was associated with significantly reduced short-term RR interval variability (supine low frequency component) (5.45+/-1.29 ln ms2 in smokers compared to 6.31+/-1.11 ln ms2 in nonsmokers, P < .02), as well as reduced brake index (33.5+/-14.5 in smokers v 42.1+/-16.0 in nonsmokers, P < .05). Diabetic smokers have significantly higher 24-h blood pressure compared to diabetic nonsmokers. This finding, contrasting the effect of smoking among nondiabetics, is possibly mediated by coexisting abnormal postural responses in autonomic cardiac regulation in diabetic smokers. Blood pressure elevation, persisting throughout 24 h, might be operative in the association between smoking and development of diabetic nephropathy.
吸烟是糖尿病肾病发生和进展的重要危险因素。吸烟增加蛋白尿并促进肾病的机制尚不清楚。考虑到吸烟的急性升压作用以及血压升高与糖尿病肾病发展之间的密切关联,血压升高可能与吸烟和糖尿病肾病之间的关联有关。然而,在非糖尿病患者中,反复发现吸烟者的血压低于不吸烟者。这可能是由对尼古丁持续交感神经刺激的自主调节介导的。糖尿病患者存在交感迷走神经活动调节受损的情况。在糖尿病患者中,吸烟对血压和自主神经功能的影响仍不明确。我们对24名吸烟者和24名在性别、年龄和糖尿病病程方面相匹配的不吸烟者进行了24小时动态血压监测(示波测量技术)和自主神经功能检测(短期功率谱分析以及传统检测)。所有患者均为正常白蛋白尿的胰岛素依赖型糖尿病患者。通过问卷调查评估吸烟状况,并通过测定尿可替宁进行确认。糖尿病吸烟者的24小时平均动脉血压显著更高(分别为94±6.7毫米汞柱和90±5.8毫米汞柱,P = 0.04),包括夜间舒张压更高(分别为68±7.3毫米汞柱和64±5.2毫米汞柱,P = 0.03)。吸烟者的24小时心率也显著更高(分别为80±7.2次/分钟和72±9.2次/分钟,P < 0.001)。此外,吸烟与短期RR间期变异性显著降低(仰卧位低频成分)有关(吸烟者为5.45±1.29 ln ms²,不吸烟者为6.31±1.11 ln ms²,P < 0.02),以及制动指数降低(吸烟者为33.5±14.5,不吸烟者为42.1±16.0,P < 0.05)。与糖尿病不吸烟者相比,糖尿病吸烟者的24小时血压显著更高。这一发现与吸烟在非糖尿病患者中的作用相反,可能是由糖尿病吸烟者自主心脏调节中同时存在的异常体位反应介导的。24小时持续升高的血压可能在吸烟与糖尿病肾病发展之间的关联中起作用。